WuXi AppTec's HitS unit provides one-stop Target-to-Hit services to enable companies in pharmaceuticals, biotechnology and academia to pursue their goals in drug discovery. As an innovation-driven and customer-focused unit, WuXi AppTec HitS provides solutions to help partners improve the productivity of hit discovery activities. With industry-leading capabilities such as protein science, biophysics, DNA-encoded library technology, and structure-based drug design. WuXi HitS is committed to drive toward the realization of the vision that every drug can be made and every disease can be treated.